Advertisement

Journal of Parasitic Diseases

, Volume 42, Issue 2, pp 277–286 | Cite as

Therapeutic potential effect of bone marrow-derived mesenchymal stem cells on chronic liver disease in murine Schistosomiasis Mansoni

  • Mohamed H. Hegab
  • Somia H. Abd-Allah
  • Maha S. Badawey
  • Ayman A. Saleh
  • Ashraf S. Metwally
  • Ghada M. Fathy
  • Soad M. Nada
  • Sara A. Abdel-RahmanEmail author
  • Amira A. Saleh
  • Amal fawzy
  • Mohammed Abu El-Magd
Original Article

Abstract

Some reports have shown that mesenchymal stem cells (MSCs) therapy could ameliorate chemically-induced hepatic fibrosis. This research assesses the therapeutic action of bone marrow mesenchymal stem cells (BM-MSCs) on chronic diseased liver in Schistosoma mansoni infected mice. All infected female mice divided into three groups, one group (15 mice) treated with oral praziquantel (PZQ), second group (15 mice) received intravenous injection of BM-MSCs and third group (15 mice) treated with both MSCs + PZQ. Two control groups (15 mice each) subdivided into one infected and second healthy one. BM-MSCs were obtained from bones of both femur and tibia of male mice (30 mice), then cultured and characterized morphologically by detection of CD105 by flow cytometer. Liver tissues for all groups were examined histopathologically. Measuring of the collagen 1 gene expression was done by real-time PCR and immunohistochemical study to detect stem cells differentiation for detection of MSCs engraftments in liver tissue. MSCs treatment caused marked improvement and regression of fibrosis, and prevents deposition of collagen and reduced the expression of collagen 1 gene in infected mice on their liver tissues, especially when used with PZQ in mice treatment. It can be concluded that, MSCs is a good therapeutic method for liver fibrosis caused by S. mansoni infection.

Keywords

MSCs Schistosoma mansoni Praziquantel Collagen 1 gene OV-6 

Notes

Acknowledgements

We thank Dr.Soheir Sayed Mahmoud, Professor of Parasitology in Theodor Bilharze Research Institute, for her valuable advices during animal experimentation. Further we thank Dr.Olfat Aly Hammam, Professor of Pathology in Theodor Bilharze Research Institute, Egypt for her active participation in histopathological and immunohistochemical parts of this work.

Author contribution

MH Abdel-Hady and SM Nada shared in the study design and research topics. SH Abd-Allah initiated the research idea and shared in performing the laboratory work of obtaining BM-MSCs. MS Badawey shared in the study design, in performing the laboratory work, and reviewing the manuscript. AS Metwally, GM Fathy, SA Abdel-Rahman and Amira A. Saleh shared in the laboratory work, interpretation of the results, collecting references, wrote and reviewed the manuscript. Ayman A. Saleh and MAbu El-Magd shared in real-time PCR study to detect stem cells differentiation. A fawzy, shared in performing the laboratory work of obtaining BM-MSCs, cultured and characterization.

Compliance with ethical standard

Conflict of interest

Authors declare that there is no any conflict of interests.

References

  1. Abdel Aziz M, Atta H, Mahfouz S, Fouad H et al (2007) Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clin Bichem 40(12):893–899CrossRefGoogle Scholar
  2. Ahmed RH, Roshdy NK, Aref MI, Hasaan NM et al (2014) Effect of bone marrow-derived mesenchymal stem cells and umbilical cord blood-CD34+ cells on experimental rat liver fibrosis. J Stem Cell Reser and Transplant 2(301):1–6Google Scholar
  3. Ali SA, Hamed MA (2006) Effect of Ailan thus altissima and zizyphusspina-christi on bilharzial infestation in mice, Histological and histopathological studies. J Appl Sci 6(2):1437–1446Google Scholar
  4. Ali G, Masoud MS (2012) Bone marrow cells ameliorate liver fibrosis and express albumin after transplantation in CCl4-induced fibrotic liver. Saudi J Gastroenterol 18(4):262–267CrossRefGoogle Scholar
  5. Anan H, Zidan R, Shaheen M, Abd El-Fattah E (2016) Theraputic efficacy of bone marrow derived mesenchymal stromal cells versus Losartan in adriamycin-induced renal cortical injury in adult albino rats. Cytotherapy 18(8):970–984CrossRefPubMedGoogle Scholar
  6. Andrade ZA (2009) Schistosomiasis and liver fibrosis. Parasite Immunol 31(11):656–1147CrossRefPubMedGoogle Scholar
  7. Bartley PB, Ramm GA, Jones MK, Ruddell RG, Li Y, McManus DP (2006) A contributory role for activated hepatic stellate cells in the dynamics of Schistosoma japonicum egg-induced fibrosis. Int J Parasitol 36:993–1001CrossRefPubMedGoogle Scholar
  8. Calabro L, Donsatti E, Bellomo G, Alonci A, Collizzi F, SigalottiL Altomonte M, MusolinoC Maio M (2003) Differential levels of soluble endoglin (CD105) in myeloid malignancies. J Cell Physiol 194:171–175CrossRefPubMedGoogle Scholar
  9. Chang YJ, Liu JW, Lin PC, Sun LY et al (2009) Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis. Life Sci 85:517–525CrossRefPubMedGoogle Scholar
  10. Dahlke MH, Schlitt HJ (2003) Making hepatocytes from stem cells: where are you? Liver Transpl 9(10):1100–1101CrossRefPubMedGoogle Scholar
  11. Dai L, Li H, Guan L, Ritchie G, Zhou J (2009) The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis. Stem Cell Res 2(1):16–25CrossRefPubMedGoogle Scholar
  12. Di Campli C, Piscaglia AC, Pierelli L et al (2004) A human umbilical cord stem cell rescue therapy in amurine model of toxic liver injury. Dig Liver Disease 36:603–613CrossRefGoogle Scholar
  13. Elkhafif N, Yehia H, Voss B, Hammam OA, Akl M, Mansy S, Mahmoud S, ElBendary O, El Fandy G (2008) Differentiation and homing of transplanted bone marrow cells in livers of murine schistosomiasis: Pilot study. Aust J Basic Appl Sci 2:1362–1372Google Scholar
  14. Elkhafif N, Voss B, Hammam O, Yehia H, Mansy S, Akl M, Boehm S, Mahmoud S, ElBendary O, El Fandy G (2010) Homing of transplanted bone marrow cells in livers of Schistosoma mansoni-infected mice. APMIS 118:277–287CrossRefPubMedGoogle Scholar
  15. El-Mahdi MM, Mansour WA, Hammam O, Mehana NA, Hussein TM (2014) Ameliorative effect of bone marrow-derived stem cells on injured liver of the mice infected with Schistosoma mansoni. Korean H Parasitol 52(2):5–162Google Scholar
  16. Fang B, Shi M, Liao L, Yang S, Liu Y, Zhao RC (2004) Systemic infusion of FLK1-mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation 78:83–88CrossRefPubMedGoogle Scholar
  17. Fausto N, Campbell JS (2003) The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev 120:117–130CrossRefPubMedGoogle Scholar
  18. Fikry H, Abdel Gawad S, Baher W (2016) Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver injury induced by Schistosoma mansoni, A histological study. Int J Stem Cells 9(1):96–106CrossRefPubMedPubMedCentralGoogle Scholar
  19. Ghanem LY, Dahman U, Dirsch O, Nosseir MM et al (2010) Does granulocyte-colony stimulating factor administrations induce damage or repair response in schistosomiasis. World J Hepatol 2:434–441CrossRefPubMedPubMedCentralGoogle Scholar
  20. Hardjo M, Miyazaki M, Sakaguchi M, Massaka T et al (2009) Suppression of carbon tetrachloride-induced liver fibrosis by transplantation of a clonal mesenychymal stem cells line derived from rat bone marrow. Cell Transplant 18(1):89–99CrossRefPubMedGoogle Scholar
  21. Haridass D, Narain N, Ott M (2008) Hepatocyte transplantation waiting for stem cells. Curr Opin Organ Transplant 13:627–632CrossRefPubMedGoogle Scholar
  22. Herrera MB, Bussolati B, Bruno S, Morando L, Mauriello-Romanazzi G, Sanavio F, Stamenkovic I, Biancone L, Camussi G (2007) Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int 72:430–441CrossRefPubMedGoogle Scholar
  23. Hsu SM, Raine L (1981) Use of avidin-biotin peroxides complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabeled antibody (PAP) procedure. J Histochem 29:577–580Google Scholar
  24. Junqueira LC, Bignolas G, Brentani RR (1978) Picrosirus staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11:447–455CrossRefGoogle Scholar
  25. Kanazawa Y, Verma IM (2003) Little evidence of bone marrow-derived hepatocytes in the replacement of injured liver. Proc Natl Acad Sci USA 100(1):11850–11853CrossRefPubMedPubMedCentralGoogle Scholar
  26. Kinnaird T, Stabile E, Burnett MS, Shou M et al (2004) Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109:1543–1549CrossRefPubMedGoogle Scholar
  27. Kollet O, Shivtiel S, Chen YQ, Suriawinata J, Spiegel A (2003) HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cells recruitment to the liver. J Clin Invest 112:160–169CrossRefPubMedPubMedCentralGoogle Scholar
  28. Li L, Zhang S, Zhang Y, Yu B, Xu Y, Guan Z (2009) Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure. Mol Biol Rep 36:725–731CrossRefPubMedGoogle Scholar
  29. Moriya K, Yoshikawa M, Ouji Y, Saito K et al (2008) Embryonic stem cells reduce liver fibrosis in CCl4-treated mice. Int J Exp Pathol 89(6):401–409CrossRefPubMedPubMedCentralGoogle Scholar
  30. Mohsen S, Shams S, Ali G, Khan M et al (2011) Enhanced hepatic differentiation of mesenchymal stem cells after pretreatment with injured liver tissue. Differentiation 81:42–48CrossRefGoogle Scholar
  31. Oliveira AS, Souza FSB, Ferreira CAG, Barreto SE et al (2008) Therapy with bone marrow cells reduces liver alterations in mice chronically infected by S. mansoni. World J Gastroentero 114(38):5842–5850CrossRefGoogle Scholar
  32. Pan Y, Dong S, Hao Y, Zhou Y, Ren X, Wang I, Wang Y, Chu T (2010) Ultrasonic-assisted extraction process of crude polysaccharides from Yinzhi mushroom and its effect on hydroxyproline and glycosaminoglycan levels. Carbohyd Polym 81:93–96CrossRefGoogle Scholar
  33. Petersen BE, Bowen WC, Patrene KD, Mars WM et al (1999) Bone marrow as a potential source of hepatic oval cells. Sci J 284:1168–1170CrossRefGoogle Scholar
  34. Prosser CC, Yen RD, Wu J (2006) Molecular therapy for hepatic injury and fibrosis: where are we? World J Gastroenterol 12(4):409–415CrossRefGoogle Scholar
  35. Pulavendran S, Vignesh J, Rose C (2010) Differential anti-inflammatory and antifibrotic activity of transplanted mesenchymal vs hematopoitic stem cells in carbon tetrachloride-induced liver injury in mice. Int Immunopharmacol 10:513–519CrossRefPubMedGoogle Scholar
  36. Ranque S, Dessein A (2001) Schistosoma mansoni schistosomiasis. Rev Prat 51(19):2099–2103PubMedGoogle Scholar
  37. Sakaida I, Terai S, Yamamoto N, Aoyama K et al (2004) Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology 40:1304–1311CrossRefPubMedGoogle Scholar
  38. Schiffmann R, Medin J, Ward J, Stahl S et al (1995) Transfer of the human glucocerebrosidase gene into hematopoietic stem cells of nonablated recipients: successful engraftment and long-term expression of the transgene. Blood 86:1218–1227PubMedGoogle Scholar
  39. Shao CH, Chen SL, Dong TF, Chai H et al (2014) Transplantation of bone marrow-derived mesenchymal stem cells after regional hepatic irradiation ameliorates thioacetamide-induced liver fibrosis in rats. J Surg Resear 186:408–416CrossRefGoogle Scholar
  40. Silva G, Litovsky S, Assad JA, Sousa AL et al (2005) Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density and improve heart function in a canine chronic ischemia model. Circulation 111:150–156CrossRefPubMedGoogle Scholar
  41. Snedecor G, Cochran W (1980) Statistical methods. Iowa State University Press, AmesGoogle Scholar
  42. Tokcaer-keskin Z, Akar AR, Ayaloglu-Butun F et al (2009) Timing of induction of cardiomyocyte differentiation for in vitro cultured mesenchymal stem cells: a perspective for emergencies. Can J Physiol Pharmacol 87:143–150CrossRefPubMedGoogle Scholar
  43. Wang X, Foster M, Al-Dhalimy M, Lagasse E, et al (2003) The origin and liver repopulating capacity of murine oval cells. Proc Nutl Acad SA USA 100(1):11881–11888CrossRefGoogle Scholar
  44. Wel X, Yang X, Han Z, Qu F et al (2013) Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin 34:747–754CrossRefGoogle Scholar
  45. Wynn TA, Thompson R, Cheever AM (2004) Immunopathogenesis of schistosomiasis. Immunol Rev 201:156–167CrossRefPubMedGoogle Scholar
  46. Xu H, Qian H, Zhu W, Zhang X et al (2012) Mesenchymal stem cells relieve fibrosis of Schistosoma japonicum-induced mouse liver injury. Exp Biol Med 237(5):585–592CrossRefGoogle Scholar
  47. Zhang W, Wulboomers XF, Van Osch H, Jansen JA (2008) Hard tissue formation in a porous HA/TCP ceramic scaffold loaded with stromal cells derived from dental pulp and bone marrow. Tissue Eng Part A 14:285–294CrossRefPubMedGoogle Scholar
  48. Zhao DC, Lei JX, Chen R, Yu WH et al (2005) Bone marrow derived mesencymal stem cells protect against experimental liver fibrosis in rats. World J Gastroenterol 11(22):3431–3440CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Indian Society for Parasitology 2018

Authors and Affiliations

  • Mohamed H. Hegab
    • 1
  • Somia H. Abd-Allah
    • 2
  • Maha S. Badawey
    • 1
  • Ayman A. Saleh
    • 3
  • Ashraf S. Metwally
    • 1
  • Ghada M. Fathy
    • 1
  • Soad M. Nada
    • 1
  • Sara A. Abdel-Rahman
    • 1
    Email author
  • Amira A. Saleh
    • 1
  • Amal fawzy
    • 2
  • Mohammed Abu El-Magd
    • 4
  1. 1.Department of Parasitology, Faculty of MedicineZagazig UniversityZagazigEgypt
  2. 2.Department of Biochemistry, Faculty of MedicineZagazig UniversityZagazigEgypt
  3. 3.Department of Animal Wealth Development, Genetics & Genetic Engineering, of Veterinary MedicineZagazig UniversityZagazigEgypt
  4. 4.Department of Anatomy & Embryology, Faculty of Veterinary MedicineKafrelsheikh UniversityKafrelsheikhEgypt

Personalised recommendations